269 related articles for article (PubMed ID: 31028563)
41. Sympathetic nervous system behavior in human obesity.
Davy KP; Orr JS
Neurosci Biobehav Rev; 2009 Feb; 33(2):116-24. PubMed ID: 18602694
[TBL] [Abstract][Full Text] [Related]
42. Advances in our understanding of the role of the sympathetic nervous system in obesity.
Macdonald IA
Int J Obes Relat Metab Disord; 1995 Dec; 19 Suppl 7():S2-S7. PubMed ID: 8963367
[TBL] [Abstract][Full Text] [Related]
43. Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones.
Ni XP; Butler AA; Cone RD; Humphreys MH
J Hypertens; 2006 Nov; 24(11):2239-46. PubMed ID: 17053546
[TBL] [Abstract][Full Text] [Related]
44. Understanding melanocortin-4 receptor control of neuronal circuits: Toward novel therapeutics for obesity syndrome.
Ju SH; Cho GB; Sohn JW
Pharmacol Res; 2018 Mar; 129():10-19. PubMed ID: 29329999
[TBL] [Abstract][Full Text] [Related]
45. Obesity-Induced Hypertension: Brain Signaling Pathways.
do Carmo JM; da Silva AA; Wang Z; Fang T; Aberdein N; de Lara Rodriguez CE; Hall JE
Curr Hypertens Rep; 2016 Jul; 18(7):58. PubMed ID: 27262997
[TBL] [Abstract][Full Text] [Related]
46. Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?
Lambert EA; Straznicky NE; Dixon JB; Lambert GW
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H244-58. PubMed ID: 25980020
[TBL] [Abstract][Full Text] [Related]
47. Sympathetic system activity in obesity and metabolic syndrome.
Tentolouris N; Liatis S; Katsilambros N
Ann N Y Acad Sci; 2006 Nov; 1083():129-52. PubMed ID: 17148737
[TBL] [Abstract][Full Text] [Related]
48. The sympathetic nervous system as a target for intervention in obesity.
Astrup A
Int J Obes Relat Metab Disord; 1995 Dec; 19 Suppl 7():S24-S28. PubMed ID: 8963368
[TBL] [Abstract][Full Text] [Related]
49. Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits.
Antic V; Kiener-Belforti F; Tempini A; Van Vliet BN; Montani JP
Am J Hypertens; 2000 May; 13(5 Pt 1):556-9. PubMed ID: 10826410
[TBL] [Abstract][Full Text] [Related]
50. Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs.
Noll G; Wenzel RR; Binggeli C; Corti C; Lüscher TF
Eur Heart J; 1998 Jun; 19 Suppl F():F32-8. PubMed ID: 9651733
[TBL] [Abstract][Full Text] [Related]
51. Autonomic nervous system dysregulation in pediatric hypertension.
Feber J; Ruzicka M; Geier P; Litwin M
Curr Hypertens Rep; 2014 May; 16(5):426. PubMed ID: 24633841
[TBL] [Abstract][Full Text] [Related]
52. Pathophysiology of obesity hypertension.
Hall JE
Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140
[TBL] [Abstract][Full Text] [Related]
53. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects.
Vaz M; Jennings G; Turner A; Cox H; Lambert G; Esler M
Circulation; 1997 Nov; 96(10):3423-9. PubMed ID: 9396437
[TBL] [Abstract][Full Text] [Related]
54. Pathophysiology and treatment of obesity hypertension.
Wofford MR; Hall JE
Curr Pharm Des; 2004; 10(29):3621-37. PubMed ID: 15579059
[TBL] [Abstract][Full Text] [Related]
55. Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure.
Scheen AJ
Curr Cardiol Rep; 2019 Jun; 21(8):70. PubMed ID: 31227915
[TBL] [Abstract][Full Text] [Related]
56. Sympathetic nervous system and hypertension.
DiBona GF
Hypertension; 2013 Mar; 61(3):556-60. PubMed ID: 23357181
[No Abstract] [Full Text] [Related]
57. Obesity, metabolism, and the sympathetic nervous system.
Landsberg L; Krieger DR
Am J Hypertens; 1989 Mar; 2(3 Pt 2):125S-132S. PubMed ID: 2647103
[TBL] [Abstract][Full Text] [Related]
58. Modulation of blood pressure by central melanocortinergic pathways.
Greenfield JR; Miller JW; Keogh JM; Henning E; Satterwhite JH; Cameron GS; Astruc B; Mayer JP; Brage S; See TC; Lomas DJ; O'Rahilly S; Farooqi IS
N Engl J Med; 2009 Jan; 360(1):44-52. PubMed ID: 19092146
[TBL] [Abstract][Full Text] [Related]
59. The sympathetic nervous system in obesity hypertension.
Lohmeier TE; Iliescu R
Curr Hypertens Rep; 2013 Aug; 15(4):409-16. PubMed ID: 23677623
[TBL] [Abstract][Full Text] [Related]
60. Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome.
Landsberg L
Ann N Y Acad Sci; 1999 Nov; 892():84-90. PubMed ID: 10842654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
